ID 3970 -
Wasak
PL: Wasak
EN: Adhatoda vasica LEAF and WHOLE PLANT
Pdf: Justicia adhatoda L.
1. Charakterystyka żywności / składnika
The food constituent that is the subject of the health claim is Justicia adhatoda L.. The characterisation of Justicia adhatoda L. is performed by comparing data provided as conditions of use to information extracted from standard reference textbooks (see Table 2 below and Appendix C for list of standard reference textbooks used for the characterisation).
Table 2. Information on Justicia adhatoda L. from standard reference textbooks and the information provided as conditions of use.
ID Scientific name Part used Nature of the preparation Conditions of use
Text-
book
Justicia adhatoda L.
= Adhatoda vasica
Nees. = Adhatoda
zeylanica Medik.
Acanthaceae
Aerial part;
root;
Fresh juice; powder;
extracts; decoction; syrup
Dried leaf: 1-2g/day,
and equivalent
preparations.
Dried root: 0.5-
1.5g/day, and
equivalent
preparations.
2508 Adhatoda vasica Not specified. Not specified Quantity in average daily serving:
100mg/day. Two
beverages are to be
consumed daily.
Note: Not sufficiently
specified
3970 Adhatoda vasica
Leaf and whole plant
Leaf; whole
plant
Powder; aqueous extract Powder: 0.05-
0.5g/day;
Aqueous extract: 0.02-
0.25g/day.
ID 2508:
The part used and the nature of preparation are not specified and the conditions of use are not sufficiently specified. The Panel notes that the consolidated list contains insufficient information to allow a characterisation of Justicia adhatoda L..
The Panel considers that the food constituent, Justicia adhatoda L., which is the subject of the health claim, has not been sufficiently characterised.
ID 3970:
The Panel considers that the food constituent, Justicia adhatoda L., which is the subject of the health claim, has been sufficiently characterised with the following conditions of use: Powder (leaf and/or whole plant): 0.05-0.5 g/day, and aqueous extract (leaf and/or whole plant): 0.02-0.25 g/day.
2.2. Funkcjonowanie górnych dróg oddechowych (ID 3970)
The claimed effect is “respiratory”. The Panel assumes that the target population is the general population.
The claimed effect “respiratory” is not sufficiently defined. From the proposed wording the Panel assumes that the claimed effect refers to the normal function of upper respiratory tract.
The Panel considers that normal function upper respiratory tract is beneficial to human health.
3.2. Funkcjonowanie górnych dróg oddechowych (ID 3970)
One reference was cited to substantiate the claimed effect. This reference is a monograph, in which the claimed effect is stated. The Panel notes that the reference cited did not provide any scientific data that could be used to substantiate the claimed effect.
The Panel concludes that a cause and effect relationship has not been established between the consumption of Justicia adhatoda L. and normal function of the upper respiratory tract.
Warunki i możliwe ograniczenia stosowania oświadczenia
Powder: 0.5-0.05g/day; aqueous extract 0.25-0.02g/day
All over 2 years old: 2-4 years ¼ adult dose, 4-10 years half adult dose
